Very few data regarding the use of infliximab in children with very early-onset inflammatory bowel disease (VEO-IBD) have been reported.
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study
ALOI, MARIO;Strisciuglio C.;Miele E.;
2019
Abstract
Very few data regarding the use of infliximab in children with very early-onset inflammatory bowel disease (VEO-IBD) have been reported.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
